Anthropic Buys a One-Person Biotech

Anthropic acquired Mithril Medicine, the Cambridge, Massachusetts start-up whose only full-time employee was founder Cody Tranbarger. He used Claude to run contracts, logistics and data analysis across 11 contract labs and eight part-time consultants, taking two rare muscular dystrophy antibody programmes from concept to encouraging mouse data in under 18 months; a first human trial is pencilled in for as late as end-2028. Nature noted the caveat the headline skips — the village did the science — while the sector read it as a template. Anthropic’s second AI-bio deal after roughly $400 million for Coefficient Bio landed alongside Nvidia and Lilly’s plan to spend up to $1 billion over five years on a joint lab, ByteDance’s Anew Labs raising $290 million at a $1.5 billion valuation, and Isomorphic Labs in talks at a reported $40 billion-plus.